Matthew Lupo
About Matthew Lupo
Matthew Lupo is the Director of U.S. Commercial Regulatory Affairs at Bristol-Myers Squibb, with over 15 years of experience in regulatory affairs and compliance.
Company
Matthew Lupo is currently working at Bristol-Myers Squibb. He has been with the company for over 15 years, holding various roles in regulatory affairs and compliance. He has developed significant expertise in U.S. law and promotion integrity during his tenure at this global pharmaceutical company.
Title
Matthew Lupo holds two key positions at Bristol-Myers Squibb. He is the Director of U.S. Commercial Regulatory Affairs and the Associate Director of U.S. Law and Promotion Integrity. These roles involve overseeing and ensuring compliance with U.S. regulatory requirements concerning pharmaceutical marketing and commercial practices.
Education and Expertise
Matthew Lupo holds a Master's degree from Rutgers University, where he studied from 2008 to 2011. He also earned a Bachelor's degree in Bachelor of Arts from The College of New Jersey, studying from 1998 to 2002. His educational background supports his extensive expertise in regulatory affairs and promotion compliance within the pharmaceutical industry.
Background
Matthew Lupo's career at Bristol-Myers Squibb began in 2005 as a contractor in Global Labeling and Promotion Compliance. Within two years, he transitioned to a full-time role and has since gained experience in multiple positions. These include Regulatory Affairs Associate, Promotion Compliance Operations, and Manager, U.S. Law and Promotion Integrity. His career demonstrates a strong focus on regulatory and compliance functions in the pharmaceutical sector.
Achievements
Matthew Lupo has continuously advanced within Bristol-Myers Squibb, showcasing his adeptness in regulatory affairs and U.S. law and promotion integrity. His progression from contractor to key leadership positions highlights his depth of experience in compliance and operational roles. Over more than a decade, he has built a robust background in promotion compliance operations, making significant contributions to the company’s adherence to U.S. regulatory standards.